论文部分内容阅读
目的:探析波立维和泰嘉治疗冠心病的临床效果。方法:选择该院收治的冠心病患者110例为研究对象,随机将其分为两组,其中给予对照组波立维治疗,而观察组则运用泰嘉治疗,对两组的治疗效果进行比较。结果:治疗前,两组的PT、血小板计数等各项指标比较差异无统计学意义(P>0.05);治疗后,两组的PT、血小板计数等各项指标较治疗前明显改善,比较差异有统计学意义(P<0.05),但是组间比较差异无统计学意义(P>0.05);同时,两组的治疗成本比较差异有统计学意义(P<0.05)。结论:临床上运用泰嘉对冠心病患者进行治疗,不仅可以获得较好的疗效,还能降低治疗成本,减轻患者的经济负担。
Objective: To investigate the clinical effect of Bolivian and Taijia on coronary heart disease. Methods: A total of 110 patients with coronary heart disease admitted to our hospital were enrolled in this study. Patients were randomly divided into two groups. The patients in the control group were treated with polio, while those in the observation group were treated with Taijia. The therapeutic effects of the two groups were compared. Results: Before treatment, there was no significant difference in PT, platelet count and other indexes between the two groups (P> 0.05). After treatment, the indexes of PT and platelet count in both groups were significantly improved compared with before treatment (P <0.05), but there was no significant difference between the two groups (P> 0.05). At the same time, the treatment cost of the two groups had significant difference (P <0.05). Conclusion: The clinical use of Taya on patients with coronary heart disease can not only achieve better curative effect, but also reduce the cost of treatment and reduce the financial burden on patients.